Phcog.Net logo
Submit

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Pharmacognosy MagazineNOW IN
    Article

    Anti‑cancer effect Shikonin on Ferric Nitrilotriacetate‑induced Renal Cancer Rats Apoptosis Mediating PEG2/NF‑κB Signaling Pathway

    Dong Wang1, Yahong Lu1, Wenjing Meng1, Tao Shu1★, Zengyue Yang1★ Corresponding author

    1. 1Department of Urology Surgery, Xi’an International Medical Center Hospital, Xi’an, China.

    CORRESPONDENCE

    Tao Shu

    Department of Urology Surgery, Xi’an International Medical Center Hospital, Xi’an, China.

    shutaogjyx@sina.com

    Received: 08-11-2021; Revised: 02-03-2022; Accepted: 01-08-2022.

    Volume 18, Issue 80 · pp. 1170–1176 · PUBLISHED 23 November 2022 · DOI: 10.4103/pm.pm_517_21

    View on Pharmacogn. Mag. original site ↗

    ABSTRACT

    Objectives: The research aimed to study the anti‑cancer effect of SKN in diethylnitrosamine (DEN) and ferric nitrilotriacetate (Fe‑NTA)‑induced renal carcinoma in rats. Materials and Methods: The experimental animal groups consisted of Group I (Control), Group II (DEN + Fe‑NTA), Group III (DEN + SKN), and Group IV (SKN alone). Retroperitoneal infusions were given for 24 weeks. Subsequently, tissues and blood samples were tested for biochemical, histopathologic, enzyme‑linked immunosorbent assay, and western blot tests. Results: After 24 weeks, the antioxidant enzymes were found to increase in the SKN‑treated groups. Histopathology revealed normal tissue morphology with a significantly reduced inflammatory response in SKN‑treated animal groups compared to the control group. The serum levels of necrosis factor kappa B, PGE2, interleukin‑1β, interleukin‑6, and tumor necrosis factor‑alpha were also down‑regulated in the SKN‑treated animal groups. The apoptotic proteins (Caspase‑3, ‑9, and Bcl‑2‑associated X protein) were higher confirming SKN‑induced apoptosis. Conclusion: Overall evidence suggests that SKN exhibits a reno‑protective anti‑cancer effect against DEN + Fe‑NTA induced renal carcinoma in rats. Thus, SKN emerges as a therapeutic agent for kidney cancer therapy.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Wang, D., Lu, Y., Meng, W., Shu, T., & Yang, Z. (2022). Anti‑cancer effect Shikonin on Ferric Nitrilotriacetate‑induced Renal Cancer Rats Apoptosis Mediating PEG2/NF‑κB Signaling Pathway. Pharmacognosy Magazine, 18(80), 1170–1176. https://doi.org/10.4103/pm.pm_517_21